2026 Regular Session
HB766
Provides relative to coverage for orally administered anti-cancer medications (EN +$66,367 SG EX See Note)
Legislative progress
i
This summary includes only completed milestones supported by recorded actions. It does not predict the next step, and it preserves later committee reassignments, concurrence, conference, veto, and approval actions when they occur.
Recorded floor votes
3 roll calls are available for this bill. This record includes procedural and intermediate action as well as substantive final votes.
May 11, 2026 · House
House Vote on HB 766 FINAL PASSAGE (#1136)
Passed ⭐ Substantive final action
93 yea–0 nay · 12 absent
May 26, 2026 · Senate
Senate Vote on HB 766 FINAL PASSAGE (#1341)
Passed ⭐ Substantive final action
37 yea–0 nay · 2 absent
May 29, 2026 · House
House Vote on HB 766 CONCUR IN SENATE AMENDMENTS (#1694)
Passed
97 yea–0 nay · 8 absent
Committee referrals
May 13, 2026 · Senate
Insurance
April 9, 2026 · House
Appropriations
February 27, 2026 · House
Insurance
Instrument history
i
This is the complete recorded action history in the current source package. Highlighted entries are marked as significant by the source. A roll-call link appears only when a vote-like action has one unambiguous same-day chamber vote.
-
House Effective date: 08/01/2026.
-
House Signed by the Governor. Becomes Act No. 833.
-
House Sent to the Governor for executive approval.
-
Senate Signed by the President of the Senate.
-
House Enrolled and signed by the Speaker of the House.
-
House Read by title, roll called, yeas 97, nays 0, Senate amendments concurred in.
-
House Scheduled for concurrence on 05/29/2026.
-
House Received from the Senate with amendments.
-
Senate Rules suspended. Senate floor amendments read and adopted. Read by title, passed by a vote of 37 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled. View roll call
-
Senate Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.
-
Senate Committee amendments read and adopted. Read by title and referred to the Legislative Bureau.
-
Senate Reported with amendments.
-
Senate Read second time by title and referred to the Committee on Insurance.
-
Senate Received in the Senate. Read first time by title and placed on the Calendar for a second reading.
-
House Read third time by title, amended, roll called on final passage, yeas 93, nays 0. Finally passed, title adopted, ordered to the Senate. View roll call
-
House Called from the calendar.
-
House Scheduled for floor debate on 05/11/2026.
-
House Notice given.
-
House Read by title, returned to the calendar.
-
House Scheduled for floor debate on 05/07/2026.
-
House Read by title, amended, ordered reengrossed, passed to 3rd reading.
-
House Reported with amendments (18-0).
-
House Read by title, amended, ordered engrossed, recommitted to the Committee on Appropriations.
-
House Reported with amendments (10-0).
-
House Read by title, under the rules, referred to the Committee on Insurance.
-
House First appeared in the Interim Calendar on 2/27/2026.
-
House Under the rules, provisionally referred to the Committee on Insurance.
-
House Prefiled.